Alexandra Blaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandra Blaga has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alexandru Gligor
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timisoara, Romania
1 shared publication - Ionica Iancu
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timisoara, Romania
1 shared publication - Janos Degi
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timisoara, Romania
1 shared publication - Livia Stanga
Department XIV—Microbiology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication - Paula Nistor
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timisoara, Romania
1 shared publication - Tiana Florea
Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timișoara, Romania
1 shared publication
Latest Publications
- Open Access
Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study
Background: Chronic progressive lymphedema (CPL) in draft horses is frequently complicated by secondary cutaneous infection, and Pseudomonas aeruginosa may be difficult to eliminate. This study evaluated topical 2% acetic acid as an adjunct to a standardized local treatment protocol. Methods: Records of 35 hospitalized horses with CPL in which P. aeruginosa was the sole pretreatment isolate were reviewed retrospectively. Seven historical controls received clipping, chlorhexidine cleansing, drying, and polyhexanide irrigation; 28 horses received the same protocol plus 2% acetic acid twice daily. No horse received systemic antimicrobials. Follow-up cultures were collected 24 h after clinical resolution. Results: Median treatment duration was 12 days (IQR 11–14) in controls and 8 days (IQR 7–9) with acetic acid (p < 0.001). P. aeruginosa clearance was achieved in 1/7 (14.3%) and 27/28 (96.4%) horses, respectively (p < 0.001). Subsequent clinical reappearance of P. aeruginosa-associated disease occurred in 6/7 (85.7%) and 3/28 (10.7%) horses (p < 0.001); most control events reflected persistence rather than recurrence after clearance. No local adverse reactions were recorded. Conclusions: Adding topical 2% acetic acid was associated with higher P. aeruginosa clearance, shorter treatment, and fewer subsequent clinical reappearances. Prospective randomized studies are needed to confirm these findings.
Open AccessClinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study
Background: Chronic progressive lymphedema (CPL) in draft horses is frequently complicated by secondary cutaneous infection, and Pseudomonas aeruginosa may be difficult to eliminate. This study evaluated topical 2% acetic acid as an adjunct to a standardized local treatment protocol. Methods: Records of 35 hospitalized horses with CPL in which P. aeruginosa was the sole pretreatment isolate were reviewed retrospectively. Seven historical controls received clipping, chlorhexidine cleansing, drying, and polyhexanide irrigation; 28 horses received the same protocol plus 2% acetic acid twice daily. No horse received systemic antimicrobials. Follow-up cultures were collected 24 h after clinical resolution. Results: Median treatment duration was 12 days (IQR 11–14) in controls and 8 days (IQR 7–9) with acetic acid (p < 0.001). P. aeruginosa clearance was achieved in 1/7 (14.3%) and 27/28 (96.4%) horses, respectively (p < 0.001). Subsequent clinical reappearance of P. aeruginosa-associated disease occurred in 6/7 (85.7%) and 3/28 (10.7%) horses (p < 0.001); most control events reflected persistence rather than recurrence after clearance. No local adverse reactions were recorded. Conclusions: Adding topical 2% acetic acid was associated with higher P. aeruginosa clearance, shorter treatment, and fewer subsequent clinical reappearances. Prospective randomized studies are needed to confirm these findings.